Krishna Menon
Scientific Advisor
Microbiology
Biotech Umea
Sweden
Biography
Krishna Menon, Ph.D., Scientific Advisor, Research & Development, AR Biosystems Dr. Menon has more than 30 years of experience in drug development with academia and industry. He is a co-founder of Cellceutix and has served as President and Director since inception in June 2007. He was the founder of KARD Scientific in 2002, a CRO specializing in cancer therapeutics development. Prior to that, Dr. Menon served at Eli Lilly as Group Leader, Cancer In Vivo Research and Clinical Development. Dr. Menon operated his own veterinary oncology and drug development consultancy practice. Earlier in his career, he held research scientist positions at Miles Laboratories and Dana Farber Cancer Research Institute, where he worked under the direction of Dr. Emil Frei, one of the world’s leading oncologists and a leader in medical research. Dr. Menon is a trained veterinary surgeon and holds a Ph.D. in Pharmacology. His Ph.D. work focused on anti-folate therapy of various cancers.
Research Interest
Microbiology
